A novel apramycin resistance gene, apmA, was detected on the ca.-40-kb resistance plasmid pAFS11 from bovine methicillin-resistant Staphylococcus aureus (MRSA) of sequence type 398 (ST398). The apmA gene coded for a protein of 274 amino acids that was related only distantly to acetyltransferases involved in chloramphenicol or streptogramin A resistance. NsiI deletion of apmA resulted in a 16-to 32-fold decrease in the apramycin MICs. An apmA-specific PCR identified this gene in one additional bovine and four porcine MRSA ST398 isolates.
Methicillin-resistant Staphylococcus aureus (MRSA) of sequence type 398 (ST398) has been identified mainly as a colonizer of the skin and the mucosal surfaces of swine (6, 26, 28) , although, more rarely, such isolates have also been found to be involved in infections of swine (9, 17, 18, 24) . Moreover, MRSA ST398 has also been detected in other animals, such as cattle (8, 23) , horses (25, 27) , poultry (15) , dogs (16) , and rats (22) , and in humans with exposure to MRSA ST398-colonized animals (7, 20, 28, 30) . As a colonizer, MRSA ST398 is subject to selective pressure by antimicrobial agents that are not used primarily to control staphylococcal infections and, as a consequence, may acquire novel or uncommon resistance genes. One such example is provided by the observation that chloramphenicol-resistant MRSA ST398 isolates from swine (9) and cattle (8) did not carry any of the usually found staphylococcal cat genes for chloramphenicol resistance (19) but harbored the phenicol exporter gene fexA, which also confers resistance to florfenicol. Florfenicol is a fluorinated chloramphenicol derivative that is widely used for the control of respiratory tract infections in cattle and swine. Another example is apramycin resistance.
Apramycin is an aminocyclitol antibiotic that is used exclusively in veterinary medicine for the treatment of Escherichia coli infections in swine, cattle, sheep, poultry, or rabbits. Studies of apramycin-resistant Enterobacteriaceae identified the gene aac(3)-IV, which is located mostly on plasmids and confers resistance to apramycin and gentamicin (2, 3, 5, 21, 29) . In contrast to the wealth of data available for apramycin resistance in Enterobacteriaceae (1, 31, 32) , no information about apramycin resistance in staphylococci exists.
During two survey studies on MRSA ST398 from diseased swine and dairy cattle, 4/54 porcine and 2/16 bovine isolates revealed high apramycin MIC values of Ն32 g/ml (8, 9) . These isolates were tentatively classified as resistant, although no clinical breakpoints for apramycin approved by the Clinical Laboratory Standards Institute (CLSI) are currently available (4) . One of these isolates, the bovine MRSA isolate 11, was chosen for further analysis of the genetic basis of apramycin resistance. The bovine MRSA isolate 11 carried a staphylococcal cassette chromosome mec element of type V (SCCmec V) and displayed the multilocus sequence type (MLST) ST398, the spa type t2576, and the dru type dt11a (8) . Plasmid analysis identified the ca.-40-kb plasmid pAFS11, which, upon transformation into S. aureus RN4220, mediated a multiresistance phenotype ( Table 1) . The corresponding resistance genes were detected by specific PCR assays (8, 9, 14) . In addition to kanamycin and neomycin resistance via aadD, macrolide-lincosamide-streptogramin B resistance via erm(B), tetracycline resistance via tet(L), and trimethoprim resistance via dfrK, plasmid pAFS11 conferred a high apramycin MIC of Ն128 g/ml. The S. aureus RN4220 transformant carrying pAFS11, however, was classified as intermediate to gentamicin (MIC of 8 g/ml) ( Table 1 ).
An 11,312-bp EcoRI fragment of pAFS11 was cloned into pBluescript II SKϩ (Stratagene). Recombinant plasmids were transformed into E. coli strain JM101, and transformants were selected on apramycin-supplemented Luria-Bertani agar (15 g/ml). Sequence analysis was conducted by primer walking starting with M13 universal and reverse primers. A schematic representation of the seven reading frames found on this EcoRI fragment is shown in Fig. 1 . This segment comprised part of a Tn917 transposon with one terminal repeat and the entire erm(B) gene. A reading frame for a 315-amino-acid (aa) protein with 30.9 and 31.4% identity to distinctly larger chromosome replication initiation/membrane attachment proteins of Staphylococcus hominis (NCBI accession no. ZP_04059882) and Staphylococcus warneri (NCBI accession no. ZP_04678490), respectively, was detected. Further downstream was the reading frame for a 263-aa ParA protein that corresponded closely (96.2 and 95.1% identity, respectively) to the chromosome partitioning ATPases of Staphylococcus capitis (NCBI accession no. ZP_03614545) and S. aureus (NCBI accession no. ACY12632). A complete IS257 element was identified, but this did not exhibit 8-bp direct repeat sequences in the upand downstream segments. The lack of these direct repeats suggested that recombination events via this insertion sequence have occurred. A complete reading frame for a 347-aa protein and the 3Ј end of a reading frame (190 aa) showed 48.4% and 54.5% identity to IcaC (NCBI accession no. YP_189846) and IcaB (NCBI accession no. YP_189845), respectively, from a Staphylococcus epidermidis isolate.
To confirm the role of the seventh reading frame, designated apmA, in apramycin resistance, the EcoRI fragment was digested with NsiI, which cuts once within the apmA reading frame, once within the IS257 sequence, and once within the icaB-like gene. Deletion clones in E. coli JM101 were tested for their apramycin MICs by broth microdilution according to the CLSI document M31-A3 (4). In comparison to clones carrying the original EcoRI fragment, all three deletion clones showed a 16-to 32-fold decrease in the apramycin MICs and also an 8-fold decrease in the gentamicin MICs. The apmA gene codes for a 274-aa protein that shows limited similarity to other proteins deposited in the databases. The best matches were 38.1% identity to a VatB-like xenobiotic acetyltransferase protein from Pasteurella multocida (NCBI accession no. NP_246134) and 33.3% identity to a putative chloramphenicol acetyltransferase from Escherichia fergusonii (NCBI accession no. YP_002383245). Based on the apmA sequence, a PCR assay using the primers apmA-fw (5Ј-CGTTTGCTTCGTGC ATTAAA-3Ј) and apmA-rev (5Ј-TTGACACGAAGGAGGG TTTC-3Ј) (annealing temperature, 52°C; amplicon size, 656 bp) was developed and applied to MRSA ST398 isolates. While the remaining bovine and the four porcine apramycinresistant isolates were positive for apmA, the isolates with MICs of Յ16 g/ml were negative. All five additional isolates harbored SCCmec V and showed the spa type t011 and the dru type dt11a (8, 9) . Transfer and hybridization experiments identified apmA in all five cases on plasmids of ca. 40 kb that were indistinguishable from or closely related to pAFS11 in their EcoRI, HindIII, BglII, and PvuI restriction patterns. All of these plasmids also harbored tet(L), dfrK, aadD, and erm(B) in addition to apmA.
Recent studies on antimicrobial resistance genes in MRSA ST398 led to the identification of a number of novel or unusual resistance genes, such as dfrK (10) , vga(C) (11) , erm(T) (12) , and cfr (13) . All of these genes were located on plasmids. Analysis of these plasmids suggested that recombination and cointegrate formation played a major role in the acquisition of novel resistance genes by MRSA ST398. In most of the described plasmids, insertion sequences, such as IS257 or ISSau10 (10, 12) , seemed to be involved in recombination processes. This is, to the best of our knowledge, the first description of an apramycin resistance gene in Gram-positive cocci. The presence of apmA on the multiresistance plasmid pAFS11 enables its persistence and coselection under the selective pressure imposed by the use of kanamycin, neomycin, tetracyclines, macrolides, lincosamides, or trimethoprim.
Nucleotide sequence accession number. The nucleotide sequence of the 11,312-bp EcoRI fragment of plasmid pAFS11 has been deposited in the EMBL database under accession number FN806789.
We thank Kerstin Meyer and Vera Nöding for excellent technical assistance.
This study was financially supported by internal funding from the Friedrich-Loeffler-Institut. 
